Selux Diagnostics is developing a Next-Generation Phenotyping (NGP) platform that promises to transform infectious disease patient treatment by dramatically increasing the speed and accuracy with which targeted, personalized antibiotic therapies can be prescribed. Earlier, better-informed treatment decisions will save lives, improve patient outcomes, decrease hospital lengths of stay and hospital-acquired infections, and help combat the global antibiotic resistance epidemic. 

Biotechnology

Selux Diagnostics

Selux Diagnostics' headquarters in Boston, MA, United States

Steve Lufkin

Aleksandar Vacic

Selux Diagnostics

Org chart

Teams

Engineering and Technical Development

Clinical Operations and Management

Marketing and Sales

Leadership Team

Quality Assurance and Compliance

Offices

Similar companies